A CASE OF SYSTEMIC SCLEROSIS SINE SCLERODERMA-ASSOCIATED INTERSTITIAL LUNG DISEASE WITHOUT A POSITIVE ANA?

被引：0
|
作者：
Djondo, Daniel
机构：
来源：
CHEST | 2018年 / 154卷 / 04期
关键词：
D O I：
10.1016/j.chest.2018.08.861
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：957A / 957A
页数：1
相关论文
共 50 条
  • [11] Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease
    Zamora, Ana C.
    Wolters, Paul J.
    Collard, Harold R.
    Connolly, M. Kari
    Elicker, Brett M.
    Webb, W. Richard
    King, Talmadge E., Jr.
    Golden, Jeffrey A.
    RESPIRATORY MEDICINE, 2008, 102 (01) : 150 - 155
  • [12] Cardiovascular comorbidity in Danish patients with scleroderma-associated interstitial lung disease
    Madsen, Gitte Anna
    Hyldgaard, Charlotte
    Bendstrup, Elisabeth
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [13] Interstitial lung disease (ILD) as a sole manifestation of visceral involvement in systemic sclerosis sine scleroderma (ssSSc)
    Gala, B
    Kanagarajan, K
    Rupanagudi, V
    Dhar, S
    Doshi, R
    Krishnan, P
    CHEST, 2004, 126 (04) : 993S - 994S
  • [14] Predictors of Mortality and Progression in Scleroderma-Associated Interstitial Lung Disease A Systematic Review
    Winstone, Tiffany A.
    Assayag, Deborah
    Wilcox, Pearce G.
    Dunne, James V.
    Hague, Cameron J.
    Leipsic, Jonathon
    Collard, Harold R.
    Ryerson, Christopher J.
    CHEST, 2014, 146 (02) : 422 - 436
  • [15] Bioactive Plasma Mitochondrial DNA Is Associated With Disease Progression in Scleroderma-Associated Interstitial Lung Disease
    Herzog, Erica L.
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 (11) : A16 - A16
  • [16] Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?
    Hideaki Yamakawa
    Tamiko Takemura
    Tae Iwasawa
    Yumie Yamanaka
    Satoshi Ikeda
    Akimasa Sekine
    Hideya Kitamura
    Tomohisa Baba
    Shinichiro Iso
    Koji Okudela
    Kazuyoshi Kuwano
    Takashi Ogura
    BMC Pulmonary Medicine, 18
  • [17] ROLE OF NON ACID AND PROXIMAL REFLUX IN SCLERODERMA-ASSOCIATED INTERSTITIAL LUNG DISEASE
    De Lauretis, A.
    Ward, S.
    Murray, C.
    Clayman, C.
    Ong, V.
    Denton, C.
    Bikov, A.
    Visca, D.
    Lindahl, G.
    Chetta, A.
    Aiello, M.
    Wuyts, W.
    Kreuter, M.
    Maher, T.
    Stock, C.
    Wells, A. U.
    Renzoni, E.
    THORAX, 2015, 70 : A92 - A92
  • [18] Pulmonary Nocardia Farcinica Infection In A Patient With Scleroderma-Associated Interstitial Lung Disease
    Mehta, S.
    Cowan, B.
    Flynn, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [19] Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease
    Gerbino, Anthony J.
    Goss, Christopher H.
    Molitor, Jernj A.
    CHEST, 2008, 133 (02) : 455 - 460
  • [20] Kl-6 As A Predictor Of Progression In Scleroderma-Associated Interstitial Lung Disease
    Watanabe, S.
    Saeki, K.
    Waseda, Y.
    Takato, H.
    Ichikawa, Y.
    Murata, A.
    Hara, J.
    Sone, T.
    Abo, M.
    Kimura, H.
    Yasui, M.
    Kasahara, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
12345